Fri.Nov 17, 2023

article thumbnail

Obesity is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction [Cardiovascular]

ASPET

Heart failure with preserved ejection fraction (HFpEF) is a major health problem with limited treatment options. Although optimizing cardiac energy metabolism is a potential approach to treating heart failure, it is poorly understood what alterations in cardiac energy metabolism actually occur in HFpEF. To determine this, we used mice in which HFpEF was induced using an obesity and hypertension HFpEF protocol for 10 weeks.

Treatment 100
article thumbnail

What is achondroplasia?

Antidote

Achondroplasia, also known as achondroplastic dwarfism or ACH, is a rare disorder characterized by short stature, a large head, and short arms and legs. It is the most common type of skeletal dysplasia, the umbrella term that identifies hundreds of conditions , and occurs in about one in 15,000 to 35,000 births.

119
119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ketamine - a new antidepressant drug with anti-inflammatory properties [Minireview]

ASPET

Ketamine is a new, potent and rapid-acting antidepressant approved for therapy of treatment-resistant depression, which has a different mechanism of action than currently-available antidepressant therapies. It owes its uniquely potent antidepressant properties to a complex mechanism of action, which currently remains unclear. However, it is thought that it acts by modulating the functioning of the glutamatergic system, which plays an important role in the process of neuroplasticity associated wi

Therapies 100
article thumbnail

Experimental Weight-Loss Drug, Retatrutide, Slashed Fat in Livers of Obese People

Drugs.com

WEDNESDAY, Nov. 15, 2023 -- Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows. A wider study, published in June, found.

Drugs 111
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Significance of organic anion transporter 2 and organic cation transporter 2 in creatinine clearance: Mechanistic evaluation using freshly-prepared human primary renal proximal tubule cells [Metabolism, Transport, and Pharmacogenetics]

ASPET

Creatinine, a clinical marker for kidney function, is predominantly cleared by glomerular filtration, with active tubular secretion contributing to about 30% of its renal clearance. Recent studies suggested the potential involvement of organic anion transporter (OAT)2, in addition to the previously known organic cation transporter (OCT)2-mediated basolateral uptake, in creatinine active secretion.

article thumbnail

FDA Approves First At-Home Test for Chlamydia, Gonorrhea

Drugs.com

THURSDAY, Nov. 16, 2023 -- The first home test for chlamydia and gonorrhea will soon hit the market, following its approval Wednesday by the U.S. Food and Drug Administration. People will be able to buy the Simple 2 Test over-the-counter at a.

More Trending

article thumbnail

Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases

Drug Patent Watch

Researchers from West Virginia University College of Law have conducted a study examining the frequency of drug patent invalidations based on inequitable conduct. The findings, published in JAMA, shed light… The post Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 102
article thumbnail

Aminopyridines Restore Ventilation and Reverse Respiratory Acidosis at Late Stages of Botulism in Mice [Drug Discovery and Translational Medicine]

ASPET

Botulinum neurotoxin (BoNT) is a potent protein toxin that causes muscle paralysis and death by asphyxiation. Treatments for symptomatic botulism are intubation and supportive care until respiratory function recovers. Aminopyridines have recently emerged as potential treatments for botulism. The clinically approved drug 3,4-diaminopyridine (3,4-DAP) rapidly reverses toxic signs of botulism and has antidotal effects when continuously administered in rodent models of lethal botulism.

Treatment 100
article thumbnail

Measles Cases Surge Worldwide, Killing 136,000 Last Year

Drugs.com

THURSDAY, Nov. 16, 2023 -- Measles deaths are surging worldwide, prompted by a wave of infections among unvaccinated children, public health experts say. Deaths from measles increased by 43% globally in 2022 compared to the year before, resulting.

98
article thumbnail

A Pediatric Rat Model of Organophosphate-Induced Refractory Status Epilepticus: Characterization of Long-term Epileptic Seizure Activity, Neurological Dysfunction and Neurodegeneration [Neuropharmacology]

ASPET

Children are highly vulnerable to the neurotoxic effects of organophosphates (OP), which can cause neuronal developmental defects, including intellectual disability, autism, epilepsy, and related comorbidities. Unfortunately, no specific pediatric OP neurotoxicity model currently exists. In this study, we developed and characterized a pediatric rat model of status epilepticus (SE) induced by the OP diisopropylfluorophosphate (DFP) and examined its impact on long-term neurological outcomes.

Treatment 100
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Today’s guest post comes from Maria Kirsch, President of Patient Services at EVERSANA. Maria discusses the challenges patients and healthcare providers face accessing specialty therapies. She introduces us to ACTICS ® eAccess , EVERSANA’s technology platform for electronic prior authorization and benefits verification that can be used for both the pharmacy benefit and the medical benefit.

article thumbnail

Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic [Minireview]

ASPET

This article describes recent advances in the use of neurosteroids as novel anticonvulsants for refractory status epilepticus (RSE) and as medical countermeasures (MCs) for organophosphates and chemical nerve agents (OPNAs). We highlight a decade-long journey to bring the synthetic neurosteroid ganaxolone (GX) from bench to clinic. RSE, including when caused by nerve agents, is associated with devastating morbidity and permanent long-term neurological dysfunction.

Treatment 100
article thumbnail

One Part of Your Brain Could Point to the Mind's Decline

Drugs.com

THURSDAY, Nov. 16, 2023 -- Shrinkage of one of the brain's key memory centers appears to herald thinking declines, a new study finds. The region in question is the hippocampus, a two-sided structure located roughly above each ear and embedded deep.

105
105
article thumbnail

Small peptide-based nano delivery systems for cancer therapy and diagnosis [Minireview]

ASPET

Developing nano-biomaterials with tunable topology, size, and surface characteristics has shown tremendously favorable benefits in various biological and clinical applications. Among various nano-biomaterials, peptide-based drug delivery systems offer multiple merits over other synthetic systems due to their enhanced bio and cytocompatibility and desirable biochemical and biophysical properties.

Therapies 100
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Review Links Pesticides to Lower Sperm Quality in Men

Drugs.com

WEDNESDAY, Nov. 15, 2023 -- Pesticide exposure appears to be linked to lower sperm concentrations in men around the world, a new large-scale evidence review has concluded. A review of 25 studies spanning nearly 50 years found consistent links.

98
article thumbnail

Treatment of Sulfur Mustard Corneal Injury by Augmenting the DNA Damage Response (DDR): A Novel Approach [Drug Discovery and Translational Medicine]

ASPET

Sulfur mustard (SM) is a highly reactive organic chemical has been used as a chemical warfare agent and terrorist threat since WWI. The cornea is highly sensitive to SM toxicity and exposure to low vapor doses can cause incapacitating acute injuries. Exposure to higher doses can elicit persistent secondary keratopathies that cause reduced quality of life and impaired or lost vision.

DNA 100
article thumbnail

Popular 'Nicotine Pouches' Won't Help Smokers Quit: Study

Drugs.com

WEDNESDAY, Nov. 14, 2023 -- Oral nicotine pouches might be marketed as an alternative to cigarettes, but they do little to curb smokers’ nicotine cravings, a new study finds. The pouches – which contain nicotine powder and other.

Marketing 105
article thumbnail

Recent advances in delivery of peptide and protein therapeutics to the brain [Minireview]

ASPET

The classes of neuropharmaceuticals known as proteins and peptides serve as diagnostic tools and are involved in specific communication in the peripheral and central nervous systems (CNS). However, due to tight junctions resembling epithelial cells found in the blood-brain barrier (BBB) in vivo, they are typically excluded from transport from the blood to the brain.

article thumbnail

As Suicide Rates Climb, Older Men Are Most Vulnerable

Drugs.com

WEDNESDAY, Nov. 15, 2023 (Healthday News) -- As U.S. suicide rates continue to rise, new government data shows older men have become the most susceptible. In a report published Wednesday, researchers from the U.S. Centers for Disease.

article thumbnail

Ingestible electronic device detects breathing depression in patients

SCIENMAG: Medicine & Health

CAMBRIDGE, MA — Diagnosing sleep disorders such as sleep apnea usually requires a patient to spend the night in a sleep lab, hooked up to a variety of sensors and monitors.

article thumbnail

What Is Babesiosis, a Tick-Borne Illness?

Drugs.com

WEDNESDAY, Nov. 15, 2023 -- You likely know that Lyme disease can be spread by ticks, but have you heard of babesiosis? It’s a different disease caused by the bite of a deer tick, and cases are rising in the United States, scientists from the.

Disease 98
article thumbnail

Atlas Venture 2023 Year In Review

LifeSciVC

2023 couldn’t end fast enough for most of us in biopharma; its been a tough year in the capital markets, and the industry is facing it’s fair share of headwinds. Fortunately, despite all that, great science and medicine continues to advance. This month we held our 2023 Annual General Meeting for our fund’s investors and our Atlas Venture Retreat with industry executives.

Science 97
article thumbnail

Melatonin Use Skyrockets Among U.S. Kids, Study Finds

Drugs.com

WEDNESDAY, Nov. 15, 2024 -- Record numbers of children and tweens now take melatonin for sleep, potentially doing harm to their development, a new study warns. Nearly one in five school-aged kids are popping melatonin to help them rest, often with.

104
104
article thumbnail

Consumption of antibiotics in the community back to pre-pandemic levels in the European Union and European Economic Area

SCIENMAG: Medicine & Health

This year’s European Antibiotic Awareness Day (EAAD) focuses on the targets outlined in the 2023 Council Recommendation to step up efforts in the European Union (EU) against antimicrobial resistance in a One Health approach.

article thumbnail

Cancer Is More Lethal For Black and Hispanic Children: Report

Drugs.com

THURSDAY, Nov. 16, 2023 (Healthday News) -- While childhood cancer is no longer terminal for many, death rates remain higher in Black and Hispanic children, a new government report reveals. Treatments for these rare cancers have improved.

article thumbnail

First human clinical trial for pill-sized device that monitors breathing from the gut

SCIENMAG: Medicine & Health

Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose.

article thumbnail

Two Uteruses, Two Babies: One Woman's Story

Drugs.com

THURSDAY, Nov. 16, 2023 (Healthday News) -- The chances of a woman having two uteruses are rare, but the odds of becoming pregnant at the same time in each uterus are even more rare. But one Alabama woman is experiencing just that. Kelsey Hatcher.

98
article thumbnail

UK’s Rural Physician Leadership Program, Anthem Medicaid announce new rural medicine scholarships

SCIENMAG: Medicine & Health

MOREHEAD, Ky. (Nov. 17, 2023) — In celebration of National Rural Health Day, yesterday the University of Kentucky College of Medicine and Anthem Blue Cross and Blue Shield Medicaid in Kentucky announced new scholarship opportunities for UK’s Rural Physician Leadership Program (RPLP). The Anthem Rural Medicine Scholarships will provide $100,000 to offset the cost of medical school for students in the RPLP.

article thumbnail

Lilly plans new $2.5B manufacturing plant as obesity drug demand ramps up

BioPharma Drive: Drug Pricing

Following the approval of Zepbound, Lilly is adding capacity to avert shortages and restricted access.

Drugs 112
article thumbnail

Air cleaners don't stop you getting sick

Science Daily: Pharmacology News

New research shows that air filtration systems or 'air cleaners' don't stop you getting sick. Air cleaners are designed to filter pollutants or contaminants out of the air that passes through them.

article thumbnail

LSU Health’s Bailey to receive prestigious national award

SCIENMAG: Medicine & Health

New Orleans, LA – The American Psychiatric Association (APA) Foundation has selected Rahn Baily, MD, DLFAPA, ACP, Professor and Chair of Psychiatry at LSU Health New Orleans School of Medicine, as the recipient of the 2024 Solomon Carter Fuller Award.

80
article thumbnail

CDC to Release Infants' RSV Shots to Help Ease Shortage

Drugs.com

THURSDAY, Nov. 16, 2023 -- To address a continuing nationwide shortage, more than 77,000 doses of RSV shots for infants were released Thursday by the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration. The.

Disease 85
article thumbnail

Cheap medicines prevented migraine as well as expensive ones

SCIENMAG: Medicine & Health

Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity. Chronic migraine can be disabling and may prevent many, especially women, from contributing to working life. Credit: Silje Alvestad Migraine is more than just a headache.

79
article thumbnail

Empowering Collaboration in Drug Discovery: CDD Vault and the COVID Moonshot

Collaborative Drug

The collaboration's achievements include the discovery of potent antivirals, building open knowledge bases, and functioning as an information-exchange hub,

Drugs 76